BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19636204)

  • 21. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter.
    Tollin SR; Mery GM; Jelveh N; Fallon EF; Mikhail M; Blumenfeld W; Perlmutter S
    Thyroid; 2000 Mar; 10(3):235-41. PubMed ID: 10779138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
    Dong S; Xia Q; Wu YJ
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The underestimated risk of cancer in patients with multinodular goiters after a benign fine needle aspiration.
    Campbell MJ; Seib CD; Candell L; Gosnell JE; Duh QY; Clark OH; Shen WT
    World J Surg; 2015 Mar; 39(3):695-700. PubMed ID: 25446471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
    Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
    J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis.
    Viola N; Agate L; Caprio S; Lorusso L; Brancatella A; Ricci D; Sgrò D; Ugolini C; Piaggi P; Vitti P; Elisei R; Santini F; Latrofa F
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.
    Latrofa F; Ricci D; Grasso L; Vitti P; Masserini L; Basolo F; Ugolini C; Mascia G; Lucacchini A; Pinchera A
    J Clin Endocrinol Metab; 2008 Feb; 93(2):591-6. PubMed ID: 18029466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.
    Provenzale MA; Fiore E; Ugolini C; Torregrossa L; Morganti R; Molinaro E; Miccoli P; Basolo F; Vitti P
    Eur J Endocrinol; 2016 Jun; 174(6):813-20. PubMed ID: 27032694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental cancer in multinodular goitre post thyroidectomy.
    Bombil I; Bentley A; Kruger D; Luvhengo TE
    S Afr J Surg; 2014 Feb; 52(1):5-9. PubMed ID: 24881131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
    Siddiqui MA; Griffith KA; Michael CW; Pu RT
    Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
    Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
    J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma.
    Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Lacerda RX; Calsolari MR
    Thyroid; 2012 Aug; 22(8):805-8. PubMed ID: 22788117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
    Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.